Cargando…
Metabolic profiling of Shu-Yu capsule in rat serum based on metabolic fingerprinting analysis using HPLC-ESI-MS(n)
The Chinese herbal formula, Shu-Yu capsule (SYC), has been successfully used to treat depression-like disorders in clinical settings. To rapidly identify the chemical constituents of SYC and its metabolites in rat serum, a simple and sensitive liquid chromatography-tandem mass spectrometry method wa...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838164/ https://www.ncbi.nlm.nih.gov/pubmed/27052341 http://dx.doi.org/10.3892/mmr.2016.5082 |
_version_ | 1782427947041292288 |
---|---|
author | LI, FANG ZHANG, YOU-BO WEI, XIA SONG, CHUN-HONG QIAO, MING-QI ZHANG, HUI-YUN |
author_facet | LI, FANG ZHANG, YOU-BO WEI, XIA SONG, CHUN-HONG QIAO, MING-QI ZHANG, HUI-YUN |
author_sort | LI, FANG |
collection | PubMed |
description | The Chinese herbal formula, Shu-Yu capsule (SYC), has been successfully used to treat depression-like disorders in clinical settings. To rapidly identify the chemical constituents of SYC and its metabolites in rat serum, a simple and sensitive liquid chromatography-tandem mass spectrometry method was established in the present study. By comparing the retention times, MS and MS(n) spectra data in the literature and reference standards, a total of 73 compounds were identified from SYC. In rat serum, 62 components, including 13 prototype compounds and 49 metabolites were identified. Of these components, 14 metabolites were confirmed as novel metabolites of SYC. The results of the present study indicated that certain flavonoid glycosides and monoterpene glycosides were absorbed directly. Glucuronidation and sulfation were identified as the predominant metabolic pathways of the components in SYC. In addition, certain phase I reactions, including hydrolysis, demethylation and hydroxylation occurred in the rats. These results provide scientific evidence, which support further investigations of the pharmacology and mechanism of SYC. |
format | Online Article Text |
id | pubmed-4838164 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-48381642016-04-21 Metabolic profiling of Shu-Yu capsule in rat serum based on metabolic fingerprinting analysis using HPLC-ESI-MS(n) LI, FANG ZHANG, YOU-BO WEI, XIA SONG, CHUN-HONG QIAO, MING-QI ZHANG, HUI-YUN Mol Med Rep Articles The Chinese herbal formula, Shu-Yu capsule (SYC), has been successfully used to treat depression-like disorders in clinical settings. To rapidly identify the chemical constituents of SYC and its metabolites in rat serum, a simple and sensitive liquid chromatography-tandem mass spectrometry method was established in the present study. By comparing the retention times, MS and MS(n) spectra data in the literature and reference standards, a total of 73 compounds were identified from SYC. In rat serum, 62 components, including 13 prototype compounds and 49 metabolites were identified. Of these components, 14 metabolites were confirmed as novel metabolites of SYC. The results of the present study indicated that certain flavonoid glycosides and monoterpene glycosides were absorbed directly. Glucuronidation and sulfation were identified as the predominant metabolic pathways of the components in SYC. In addition, certain phase I reactions, including hydrolysis, demethylation and hydroxylation occurred in the rats. These results provide scientific evidence, which support further investigations of the pharmacology and mechanism of SYC. D.A. Spandidos 2016-05 2016-04-04 /pmc/articles/PMC4838164/ /pubmed/27052341 http://dx.doi.org/10.3892/mmr.2016.5082 Text en Copyright: © Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles LI, FANG ZHANG, YOU-BO WEI, XIA SONG, CHUN-HONG QIAO, MING-QI ZHANG, HUI-YUN Metabolic profiling of Shu-Yu capsule in rat serum based on metabolic fingerprinting analysis using HPLC-ESI-MS(n) |
title | Metabolic profiling of Shu-Yu capsule in rat serum based on metabolic fingerprinting analysis using HPLC-ESI-MS(n) |
title_full | Metabolic profiling of Shu-Yu capsule in rat serum based on metabolic fingerprinting analysis using HPLC-ESI-MS(n) |
title_fullStr | Metabolic profiling of Shu-Yu capsule in rat serum based on metabolic fingerprinting analysis using HPLC-ESI-MS(n) |
title_full_unstemmed | Metabolic profiling of Shu-Yu capsule in rat serum based on metabolic fingerprinting analysis using HPLC-ESI-MS(n) |
title_short | Metabolic profiling of Shu-Yu capsule in rat serum based on metabolic fingerprinting analysis using HPLC-ESI-MS(n) |
title_sort | metabolic profiling of shu-yu capsule in rat serum based on metabolic fingerprinting analysis using hplc-esi-ms(n) |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838164/ https://www.ncbi.nlm.nih.gov/pubmed/27052341 http://dx.doi.org/10.3892/mmr.2016.5082 |
work_keys_str_mv | AT lifang metabolicprofilingofshuyucapsuleinratserumbasedonmetabolicfingerprintinganalysisusinghplcesimsn AT zhangyoubo metabolicprofilingofshuyucapsuleinratserumbasedonmetabolicfingerprintinganalysisusinghplcesimsn AT weixia metabolicprofilingofshuyucapsuleinratserumbasedonmetabolicfingerprintinganalysisusinghplcesimsn AT songchunhong metabolicprofilingofshuyucapsuleinratserumbasedonmetabolicfingerprintinganalysisusinghplcesimsn AT qiaomingqi metabolicprofilingofshuyucapsuleinratserumbasedonmetabolicfingerprintinganalysisusinghplcesimsn AT zhanghuiyun metabolicprofilingofshuyucapsuleinratserumbasedonmetabolicfingerprintinganalysisusinghplcesimsn |